Greenwood launches Syndromic Autism 62-Gene Panel

RainDance Technologies, Inc., the Digital Biology™ Company, today announced that Greenwood Genetic Center has commercially launched its Syndromic Autism 62-Gene Panel which was built for use on RainDance's picodroplet-based targeted sequencing platform. The panel sequences 62 individual autosomal and X-linked genes that represent the most common single gene etiologies associated with Autism Spectrum Disorders (ASD) and syndromes that include autism as a significant phenotypic feature.    

"As a condition that is commonly diagnosed, it is essential that families affected by autism have access to resources that help them understand this critical healthcare challenge," said Julie Jones, PhD, FACMG, Director, Molecular Diagnostic Laboratory at Greenwood Genetic Center. "The simultaneous testing of these genes in a single study provides a significant time and cost advantage over traditional single gene sequencing. Our hope is that this panel enables the more routine use of next-generation sequencing as a tool for identifying the molecular basis of disorders that involve autism."